Latest News - CRSTodayEurope

Friday, May 19, 2017 | Health Care

AOA and J&J Executives Advocate for Optometry and Patient Safety in Capitol Hill Meetings

Industry leaders visited Capitol Hill this week to deliver a message to Congress about eyecare, patient safety and the importance of “in-person vision care” provided by optometrists. The i…

Read the full story

Thursday, May 18, 2017 | Medical Studies, Prevent Blindness

Cataract Rates Continue to Increase, Remains Leading Global Cause of Blindness

Cataract is responsible for 51 percent of world blindness, according to the World Health Organization. In the United States, the current number of those with cataract is estimated to be more than 25.7…

Read the full story

Thursday, May 18, 2017 | Medical Studies

3D-Printed 'Eyes' Could Help Blind Children's Faces Grow Naturally

Scientists and engineers are 3D printing all types of objects these days, including eyes: A group of eye specialists and eye-care providers from the Netherlands has used 3D-printing technology to…

Read the full story

Wednesday, May 17, 2017 | Acquisitions/Mergers

Quidel Completes Acquisition of InflammaDry and AdenoPlus Eye Health Businesses

Quidel announced it completed the acquisition of the InflammaDry and AdenoPlus diagnostic businesses from RPS Diagnostics for approximately $14 million in cash. The InflammaDry and AdenoPlus produc…

Read the full story

Wednesday, May 17, 2017 | Product Releases, Reichert Technologies

Reichert Technologies Introduces New Family of ClearChart 4 Digital Acuity Systems

Reichert Technologies has announced the launch of three new ClearChart Digital Acuity Systems: ClearChart 4 Digital Acuity System, ClearChart 4X Enhanced Digital Acuity System, and ClearChart 4P Polar…

Read the full story

Wednesday, May 17, 2017 | Health Care

Proposal Would Allow Optometrists to Treat Glaucoma in Massachusetts

A legislative proposal would allow optometrists in Massachusetts to treat glaucoma and prescribe oral medications for eye infections. The provision was attached as an outside section in a $40.3 billio…

Read the full story

Wednesday, May 17, 2017 | Awards

American Academy of Optometry Foundation Announces the 2017 William C. Ezell Fellowships

The American Academy of Optometry Foundation announces the 11 recipients for the 2017 William C. Ezell Fellowship program. The Ezell Fellowship program is named after the founding President of the AAO…

Read the full story

Tuesday, May 16, 2017 | Product Releases, Alcon

Alcon Introduces SYSTANE ICAPS Chewable Eye Vitamin, the First Chewable AREDS2 Formula in the United States

Alcon announced the introduction of SYSTANE ICAPS Chewable AREDS2 eye vitamin in the US market to support eye health in people with intermediate to advanced age-related macular degeneration (AMD).…

Read the full story

Tuesday, May 16, 2017 | Management/Leadership

Grand Rapids Ophthalmology Names Bill Hughson as CEO

Grand Rapids Ophthalmology (GRO), a comprehensive eye care provider offering ophthalmology, optometry, and retail optical services in West Michigan, announced  the appointment of Bill Hughson as …

Read the full story

Monday, May 15, 2017 | Medical Studies

Report: Daily Contact Lenses Surpass Monthlies in US Sales, Account for 38% of Market

Point-of-sale data from GfK shows continued strong momentum for daily contact lenses, helping to drive overall dollar growth in the US soft contact lens market. But the number of new contact lens wear…

Read the full story

Monday, May 15, 2017 | Clinical Trials, Glaucoma

Isarna Presents Positive Clinical Data for ISTH0036 in Advanced Glaucoma and Preclinical Data Supportive of AMD/DME Potential at ARVO

Isarna Therapeutics announced the presentation of the phase I safety and efficacy data for its lead candidate ISTH0036, a locked nucleic acid-modified antisense oligonucleotide, in advanced-stage glau…

Read the full story

Monday, May 15, 2017 | Clinical Trials, Glaucoma, Aerie Pharmaceuticals

Aerie Pharmaceuticals Announces FDA Acceptance of NDA Submission for Rhopressa

Aerie Pharmaceuticals reported that it has received notification from the FDA that the agency has completed its initial 60-day review of the Rhopressa new drug application (NDA) and determined that th…

Read the full story

Friday, May 12, 2017 | Clinical Trials

Pharmaleads Reports Positive Ocular Pain Results with PL265, a Novel Dual Enkephalinase Inhibitor (DENKI) at ARVO

Pharmaleads announced positive efficacy and safety results of PL265, a novel Dual ENKephalinase Inhibitor (DENKI), in a preclinical study for ocular pain. This study was conducted in collaboration wit…

Read the full story

Friday, May 12, 2017 | Medical Studies

FDA New Safety Communication Indicates Fluoroquinolones Not Linked to Retinal Detachment

As part of the FDA's ongoing review of fluoroquinolone antibiotics, the agency is informing the public that patient cases identified by the FDA and findings from published studies currently do not…

Read the full story

Friday, May 12, 2017 | Medical Studies

Re-esterified Omega-3 Supplements Effective in Dry Eye

People with dry eyes may improve their symptoms by taking re-esterified omega-3 fatty acid supplements, researchers say. Although omega-3 supplements are already a standard treatment for dry eyes in t…

Read the full story
Load More